Annual revenue of Jiangsu Hengrui Pharmaceuticals 2022, by sales channel
50 leading global pharmaceutical companies by prescription sales in 2022 and remains a market leader in oncology medications in China.
In 2022, Jiangsu Hengrui Pharmaceuticals generated more than 20 billion yuan through direct sales of its products and showed very little dependence on external distributors. The pharmaceutical giant was among the